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Results and Conclusions
149 proteins were expressed in both strains. An analysis was carried
out in order to evaluate which proteins had a higher overexpression.
Proteins with an emPai increase higher than 2.5 were selected. The
QCR2 (QCR2 gene), QCR1 (COR1 gene), ALDH4 (ALD4 gene),
ATPB (ATP2 gene), ATPA (ATP1 gene), SCW10 (SCW10 gene),
HSP26 (HSP26 gene), ATPG (ATP3 gene) and PCKA (PCK1 gene)
were analyzed.
The QCR2 gene presented co-expression with the ATP1, ATP2,
ATP3, COR1, PCK1, SCW10 and ALD4 genes. The COR1 gene
presented co-expression with the ATP1, PCK1 and SCW10 genes.
The ALD4 gene presented co-expression with the genes ATP1,
COR1, PCK1 and SCW10 genes. The ATP2 gene presented co-
expression with the SCW10, ATP1, ATP3, COR1, ALD4 and PCK1
genes. The ATP1 gene presented co-expression with the SCW10 and
PCKA1 genes. The SCW10 gene presented co-expression with the
QCR2, COR1, ALD4, ATP2, ATP3, PCK1 and ATP1 genes. The
HSP26 gene presented co-expression with the ATP1, ATP3, ALD4,
PCK1, COR1 and QCR2 genes. The ATP3 gene presented co-
expression with the genes ATP1, COR1, SCW10 and ALD4 genes.
The PCK1 gene presented co-expression with the SCW10 gene.
These proteins are implicated in hydrogen ion transmembrane
transporter activity, cellular respiration, active transmembrane
transporter activity, mitochondrial inner membrane and
mitochondrial respiratory chain.
The increase of these proteins is logical because the cells have to
increase their cellular and molecular mechanisms and produce more
proteins to resist to the drug and be able to survive.
In conclusion, the increased of expression of these proteins in the
cisplatin-resistant strain suggests that they could be involved in the
resistance process. Therefore, they could be good candidates for
biomarkers of cisplatin chemoresistance.
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Introduction
Research carried out in oncology has allowed the identification and
characterization of molecular markers of resistance to antineoplastic
drugs. It supposes a great advance and allows the administration of
customized chemotherapies to patients.
Notable successes in this field of research include the overexpression
of the HER2 protein as a molecular marker in patients with breast
cancer treated with Trastuzumab, and the deletion of exon 19 or the
substitution of exon 21 (L858R) in the EGFR gene, in patients with
metastatic non–small-cell lung treated with Erlotinib.
Several studies show that the expression of DNA repair genes such as
ERCC1, β-tubulins or Toposiomerases can predict the response to
Platinum, Taxanos and other cytotoxic agents.
While the use of predictive biomarkers in other types of cancer
therapies is something common and used, there is not yet a protocol
standardized for chemotherapy.
Thus, this shows the great importance and the need to investigate
biomarkers of resistance, with the aim of administering more effective
and personalized therapies.
Objectives
The aim of this work is to carry out a proteomic analysis in the wild
type strain and cisplatin resistant strain of Saccharomyces cerevisiae in
order to look for possible markers of resistance, as well as the
mechanisms involved.
Methodology
Protein extraction, purification and identification were carried out in
both the wild type strain and cisplatin resistant strain. The method was
an analysis by tandem mass spectrometry using a "nano HPLC-ESI-
MS / MS" ion trap system.
The exponentially modified protein abundance index (emPAI) offers a
relative quantification of proteins in a mixture.
The increase in emPAI of the resistant strain against the wild strain
was calculated by dividing the value of emPAI of the resistant strain
between that of the wild type strain.
Functions and interactions between genes that encode proteins with ΔemPAI > 2.5 in cisplatin-resistant
strain WS8105-1C-R300cisPt.
